$MLYS
Mineralys Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Radnor, PA
MLYS chart
What traders are saying about $MLYS
Latest postsMineralys Therapeutics, Inc. news
- Mineralys Therapeutics, Inc. (MLYS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Why is Mineralys Therapeutics stock climbing today? By Investing.com
Investing.com Nigeria ·
- Mineralys stock gains after drug shows sustained blood pressure cuts
Yahoo Finance ·
- Why is Mineralys Therapeutics stock climbing today?
Investing.com ·
- Mineralys Therapeutics (MLYS) Could Be 66% Undervalued Following Long Term Trial Data
Simply Wall St ·
- Mineralys Therapeutics (MLYS) Reports Promising Long-Term Data on Lorundrostat for Resistant Hypertension
GuruFocus ·
- Mineralys Therapeutics reports long-term lorundrostat data
Mugglehead Investment Magazine ·
- Mineralys Therapeutics Presents New Late-Breaking Data from...
Quantisnow ·
- Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026
Yahoo Finance ·
- Mineralys Therapeutics, Inc. (MLYS) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- What Pushes Mineralys Therapeutics (NASDAQ:MLYS) G&A to USD 37.4 Million Before December 22?
kalkine.ca ·
Mineralys Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$154.7M | -$177.8M | -$71.9M | -$29.8M |
| Diluted EPS | $-2.29 | $-3.66 | $-1.99 | $-5.77 |
| Total assets (year end) | $661.8M | $205.9M | $251.6M | $114.4M |
| Cash and equivalents (year end) | $172.9M | $114.1M | $49.3M | $87.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Mineralys Therapeutics, Inc.
- Ticker
- MLYS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Radnor, PA
- Fiscal year end
- December 31
- SEC CIK
- 1933414
Frequently asked questions
What exchange is Mineralys Therapeutics, Inc. listed on?
Mineralys Therapeutics, Inc. trades on the Nasdaq under the ticker symbol MLYS.
What industry is Mineralys Therapeutics, Inc. in?
Mineralys Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Mineralys Therapeutics, Inc. headquartered?
Mineralys Therapeutics, Inc.'s business address on file with the SEC is in Radnor, PA.
When does Mineralys Therapeutics, Inc.'s fiscal year end?
Mineralys Therapeutics, Inc.'s fiscal year ends on December 31.